BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
BOOST Pharma has raised $3.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
BOOST Pharma's investors include Sound Bioventures, Industrifonden, BioInnovation Institute, Karolinska.
BOOST Pharma is headquartered in Copenhagen, Denmark.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
BOOST Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BOOST Pharma — Funding & Investors." VCBacked, November 3, 2025, https://www.vcbacked.co/company/boost-pharma. Accessed July 19, 2026.
VCBacked. (2025). BOOST Pharma — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/boost-pharma
{{cite web |title=BOOST Pharma — Funding & Investors |url=https://www.vcbacked.co/company/boost-pharma |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated